{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:33:07Z","timestamp":1785367987748,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,7,7]],"date-time":"2015-07-07T00:00:00Z","timestamp":1436227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,7,7]],"date-time":"2015-07-07T00:00:00Z","timestamp":1436227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s10557-015-6604-7","type":"journal-article","created":{"date-parts":[[2015,7,6]],"date-time":"2015-07-06T01:16:02Z","timestamp":1436145362000},"page":"425-431","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Nifekalant Versus Amiodarone in the Treatment of Cardiac Arrest: an Experimental Study in a Swine Model of Prolonged Ventricular Fibrillation"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1695-3511","authenticated-orcid":false,"given":"George","family":"Karlis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Iacovidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavlos","family":"Lelovas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiota","family":"Niforopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apostolos","family":"Papalois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Siafaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spyros","family":"Mentzelopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Xanthos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,7]]},"reference":[{"key":"6604_CR1","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.resuscitation.2010.08.017","volume":"81","author":"CD Deakin","year":"2010","unstructured":"Deakin CD, Nolan JP, Soar J, et al. European resuscitation council guidelines for resuscitation. Section 4. Adult advanced life support. Resuscitation. 2010;81:1305\u201352.","journal-title":"Resuscitation"},{"key":"6604_CR2","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1161\/CIRCULATIONAHA.110.970988","volume":"122","author":"RW Neumar","year":"2010","unstructured":"Neumar RW, Otto CW, Link MS, et al. Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010;122:729\u201367.","journal-title":"Circulation"},{"key":"6604_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.resuscitation.2010.08.027","volume":"81","author":"CD Deakin","year":"2010","unstructured":"Deakin CD, Morrison LJ, Morley PT, et al. Part 8: advanced life support. 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Resuscitation. 2010;81:93\u2013174.","journal-title":"Resuscitation"},{"key":"6604_CR4","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1056\/NEJM199909163411203","volume":"341","author":"PJ Kudenchuk","year":"1999","unstructured":"Kudenchuk PJ, Cobb LA, Copass MK, et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med. 1999;341:871\u20138.","journal-title":"N Engl J Med"},{"key":"6604_CR5","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1056\/NEJMoa013029","volume":"346","author":"P Dorian","year":"2002","unstructured":"Dorian P, Cass D, Schwartz B, Cooper R, Gelaznikas R, Barr A. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med. 2002;346:884\u201390.","journal-title":"N Engl J Med"},{"key":"6604_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/ddr.430350202","volume":"35","author":"M Ishii","year":"1995","unstructured":"Ishii M, Kamiya J, Hashimoto K. Cellular electrophysiological effects of MS-551, a new class III antiarrhythmic agent. Drug Dev Res. 1995;35:61\u20138.","journal-title":"Drug Dev Res"},{"key":"6604_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.resuscitation.2009.09.027","volume":"81","author":"T Shiga","year":"2010","unstructured":"Shiga T, Tanaka K, Kato R, et al. Nifekalant versus lidocaine for in-hospital shock-resistant ventricular fibrillation or tachycardia. Resuscitation. 2010;81:47\u201352.","journal-title":"Resuscitation"},{"key":"6604_CR8","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1253\/circj.CJ-09-0375","volume":"73","author":"S Yusu","year":"2009","unstructured":"Yusu S, Ikeda T, Mera H, et al. Effects of intravenous nifekalant as a life saving drug for severe ventricular tachyarrhythmias complicating acute coronary syndrome. Circ J. 2009;73:2021\u20138.","journal-title":"Circ J"},{"key":"6604_CR9","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1253\/circj.70.442","volume":"70","author":"Y Tahara","year":"2006","unstructured":"Tahara Y, Kimura K, Kosuge M, et al. Comparison of nifekalant and lidocaine for the treatment of shock-refractory ventricular fibrillation. Circ J. 2006;70:442\u20136.","journal-title":"Circ J"},{"key":"6604_CR10","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1253\/circj.CJ-09-0759","volume":"74","author":"K Nagao","year":"2010","unstructured":"Nagao K. Nifekalant hydrochloride for patients with cardiac arrest caused by shockable rhythm. Circ J. 2010;74:2308\u201313.","journal-title":"Circ J"},{"key":"6604_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4330\/wjc.v3.i6.169","volume":"3","author":"IN Pantazopoulos","year":"2011","unstructured":"Pantazopoulos IN, Troupis GT, Pantazopoulos CN, Xanthos TT. Nifekalant in the treatment of life-threatening ventricular tachyarrhythmias. World J Cardiol. 2011;3:169\u201376.","journal-title":"World J Cardiol"},{"key":"6604_CR12","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/aas.12226","volume":"58","author":"G Karlis","year":"2014","unstructured":"Karlis G, Iacovidou N, Lelovas P, et al. Effects of early amiodarone administration during and immediately after cardiopulmonary resuscitation in a swine model. Acta Anaesthesiol Scand. 2014;58:114\u201322.","journal-title":"Acta Anaesthesiol Scand"},{"key":"6604_CR13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/FJC.0b013e3181d3dcc7","volume":"55","author":"M Amino","year":"2010","unstructured":"Amino M, Yoshioka K, Opthof T, et al. Comparative study of nifekalant versus amiodarone for shock-resistant ventricular fibrillation in out-of-hospital cardiopulmonary arrest patients. J Cardiovasc Pharmacol. 2010;55:391\u20138.","journal-title":"J Cardiovasc Pharmacol"},{"key":"6604_CR14","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1258\/002367707781282820","volume":"41","author":"T Xanthos","year":"2007","unstructured":"Xanthos T, Lelovas P, Vlachos I, et al. Cardiopulmonary arrest and resuscitation in Landrace\/Large White swine: a research model. Lab Anim. 2007;41:353\u201362.","journal-title":"Lab Anim"},{"key":"6604_CR15","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.resuscitation.2010.04.023","volume":"81","author":"XF Ji","year":"2010","unstructured":"Ji XF, Li CS, Wang S, Yang L, Cong LH. Comparison of the efficacy of nifekalant and amiodarone in a porcine model of cardiac arrest. Resuscitation. 2010;81:1031\u20136.","journal-title":"Resuscitation"},{"key":"6604_CR16","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1001\/jama.288.23.3035","volume":"288","author":"ML Weisfeldt","year":"2002","unstructured":"Weisfeldt ML, Becker LB. Resuscitation after cardiac arrest: a 3-phase time-sensitive model. JAMA. 2002;288:3035\u20138.","journal-title":"JAMA"},{"key":"6604_CR17","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.ajem.2008.05.004","volume":"27","author":"T Xanthos","year":"2009","unstructured":"Xanthos T, Bassiakou E, Koudouna E, et al. Combination pharmacotherapy in the treatment of experimental cardiac arrest. Am J Emerg Med. 2009;27:651\u20139.","journal-title":"Am J Emerg Med"},{"key":"6604_CR18","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.amjcard.2006.02.055","volume":"98","author":"CM Gilmore","year":"2006","unstructured":"Gilmore CM, Rea TD, Becker LJ, Eisenberg MS. Three-phase model of cardiac arrest: time-dependent benefit of bystander cardiopulmonary resuscitation. Am J Cardiol. 2006;98:497\u20139.","journal-title":"Am J Cardiol"},{"key":"6604_CR19","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s00540-013-1775-5","volume":"28","author":"N Harayama","year":"2014","unstructured":"Harayama N, Nihei SI, Nagata K, et al. Comparison of nifekalant and amiodarone for resuscitation of out-of-hospital cardiopulmonary arrest resulting from shock-resistant ventricular fibrillation. J Anesth. 2014;28:587\u201392.","journal-title":"J Anesth"},{"key":"6604_CR20","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/S0735-1097(96)00559-1","volume":"29","author":"Y Murakawa","year":"1997","unstructured":"Murakawa Y, Yamashita T, Kanese Y, Omata M. Can a class III antiarrhythmic drug improve electrical defibrillation efficacy during ventricular fibrillation? J Am Coll Cardiol. 1997;29:688\u201392.","journal-title":"J Am Coll Cardiol"},{"key":"6604_CR21","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1517\/14740338.2012.660915","volume":"11","author":"P Santangeli","year":"2012","unstructured":"Santangeli P, Di Biase L, Burkhardt JD, et al. Examining the safety of amiodarone. Expert Opin Drug Saf. 2012;11:191\u2013214.","journal-title":"Expert Opin Drug Saf"},{"key":"6604_CR22","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/01.fjc.0000248242.99337.4d","volume":"48","author":"J Ohashi","year":"2006","unstructured":"Ohashi J, Yasuda S, Miyazaki S, et al. Prevention of life-threatening ventricular tachyarrhythmia by a novel and pure class-III agent, nifekalant hydrochloride. J Cardiovasc Pharmacol. 2006;48:274\u20139.","journal-title":"J Cardiovasc Pharmacol"},{"key":"6604_CR23","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.resuscitation.2010.01.010","volume":"81","author":"T Xanthos","year":"2010","unstructured":"Xanthos T, Iacovidou N, Pantazopoulos I, et al. Ischaemia-modified albumin predicts the outcome of cardiopulmonary resuscitation: an experimental study. Resuscitation. 2010;81:591\u20135.","journal-title":"Resuscitation"},{"key":"6604_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0735-6757(85)90003-8","volume":"3","author":"AB Sanders","year":"1985","unstructured":"Sanders AB, Ogle M, Ewy GA. Coronary perfusion pressure during cardiopulmonary resuscitation. Am J Emerg Med. 1985;3:11\u20134.","journal-title":"Am J Emerg Med"},{"key":"6604_CR25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0735-1097(85)80261-8","volume":"6","author":"AB Sanders","year":"1985","unstructured":"Sanders AB, Kern KB, Atlas M, Bragg S, Ewy GA. Importance of the duration of inadequate coronary perfusion pressure on resuscitation from cardiac arrest. J Am Coll Cardiol. 1985;6:113\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"6604_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0002-9149(85)90328-5","volume":"55","author":"JT Niemann","year":"1985","unstructured":"Niemann JT, Rosborough JP, Niskanen RA, Alferness C, Criley JM. Mechanical \u201ccough\u201d cardiopulmonary resuscitation during cardiac arrest in dogs. Am J Cardiol. 1985;55:199\u2013204.","journal-title":"Am J Cardiol"},{"key":"6604_CR27","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1161\/01.CIR.77.1.240","volume":"77","author":"MP Feneley","year":"1988","unstructured":"Feneley MP, Maier GW, Kern KB, et al. Influence of compression rate on initial success of resuscitation and 24-hour survival after prolonged manual cardiopulmonary resuscitation in dogs. Circulation. 1988;77:240\u201350.","journal-title":"Circulation"},{"key":"6604_CR28","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1161\/01.CIR.75.2.498","volume":"75","author":"KB Kern","year":"1987","unstructured":"Kern KB, Sanders AB, Badylak SF, et al. Long-term survival with open-chest cardiac massage after ineffective closed-chest compression in a canine preparation. Circulation. 1987;75:498\u2013503.","journal-title":"Circulation"},{"key":"6604_CR29","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.resuscitation.2012.09.015","volume":"84","author":"I Dragancea","year":"2013","unstructured":"Dragancea I, Rundgren M, Englund E, Friberg H, Cronberg T. The influence of induced hypothermia and delayed prognostication on the mode of death after cardiac arrest. Resuscitation. 2013;84:337\u201342.","journal-title":"Resuscitation"},{"key":"6604_CR30","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1254\/fpj.119.103","volume":"119","author":"A Oyabe","year":"2002","unstructured":"Oyabe A, Sano H. Pharmacological and clinical profile of nifekalant (shinbit injection), a class III antiarrhythmic drug. Nihon Yakurigaku Zasshi. 2002;119:103\u20139.","journal-title":"Nihon Yakurigaku Zasshi"},{"key":"6604_CR31","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1253\/circj.67.898","volume":"67","author":"M Myoishi","year":"2003","unstructured":"Myoishi M, Yasuda S, Miyazaki S, et al. Intravenous administration of nifekalant hydrochloride for the prevention of ischemia-induced ventricular tachyarrhythmia in patients with renal failure undergoing hemodialysis. Circ J. 2003;67:898\u2013900.","journal-title":"Circ J"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-015-6604-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-015-6604-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-015-6604-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-015-6604-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:48:32Z","timestamp":1744174112000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-015-6604-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,7]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["6604"],"URL":"https:\/\/doi.org\/10.1007\/s10557-015-6604-7","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,7]]},"assertion":[{"value":"7 July 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}